Last reviewed · How we verify
Intravenous Antibiotic
Intravenous Antibiotic is a Small molecule drug developed by The George Institute. It is currently in Phase 3 development. Also known as: Ceftriaxone, Cefotaxime or Ciprofloxacin, Cefoperazone.
An intravenous antibiotic that inhibits bacterial protein synthesis or cell wall formation to treat infections.
At a glance
| Generic name | Intravenous Antibiotic |
|---|---|
| Also known as | Ceftriaxone, Cefotaxime or Ciprofloxacin, Cefoperazone |
| Sponsor | The George Institute |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | Phase 3 |
Mechanism of action
Intravenous antibiotics work through various mechanisms depending on the specific agent—commonly by inhibiting bacterial protein synthesis (e.g., aminoglycosides, tetracyclines), disrupting cell wall integrity (e.g., beta-lactams), or interfering with nucleic acid synthesis. The George Institute's Phase 3 candidate likely targets a specific bacterial pathogen or resistance mechanism relevant to serious infections requiring parenteral administration.
Approved indications
Common side effects
Key clinical trials
- Individualized Precision Isavuconazole Therapy Guided by PK/PD Principles for the Geriatric Population
- Intracalvariosseous Plus Intravenous Antibiotics for Moderate-to-Severe Bacterial Meningitis (NA)
- Individualized Precision Therapy With Ceftazidime and Avibactam Guided by PK/PD in Geriatric Populations
- The Personalised Antibiotic Duration for Cellulitis (PAD-C) Study
- MP101 in Adults With Acute Pseudomonas Aeruginosa Pneumonia (PHASE1)
- Vitamin C for Acute Kidney Injury in ACLF With Septic Shock: A Randomized Controlled Trial (NA)
- Duration of Cardiac Antimicrobial Prophylaxis Outcomes Study (PHASE4)
- IO Vancomycin Spine (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intravenous Antibiotic CI brief — competitive landscape report
- Intravenous Antibiotic updates RSS · CI watch RSS
- The George Institute portfolio CI
Frequently asked questions about Intravenous Antibiotic
What is Intravenous Antibiotic?
How does Intravenous Antibiotic work?
Who makes Intravenous Antibiotic?
Is Intravenous Antibiotic also known as anything else?
What development phase is Intravenous Antibiotic in?
Related
- Manufacturer: The George Institute — full pipeline
- Therapeutic area: All drugs in Infectious Disease
- Also known as: Ceftriaxone, Cefotaxime or Ciprofloxacin, Cefoperazone
- Compare: Intravenous Antibiotic vs similar drugs
- Pricing: Intravenous Antibiotic cost, discount & access